Federal investigators have launched a criminal investigation into Alere’s billing practices, focusing specifically on drug tests provided through the company’s toxicology unit, according to the Wall ...
Alere IncALR recently announced 510(k) approval from the U.S. Food and Drug Administration (FDA) for its Alere i RSV test, a unified solution of rapid and accurate diagnosis of RSV diseases. Notably, ...
WALTHAM, Mass., April 2, 2015 – Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today announced that its Alere™ i Strep A test has received marketing clearance from the U.S. Food ...
The president of the Michigan Medical Marijuana Association is concerned the saliva tests being used by police in a new roadside drug testing pilot program may have a ...
Over the summer, Abbott ($ABT) said that it was keeping an eye out for potential deals, even if it didn't want one with St. Jude ($STJ). Now, the company has landed ...
The FDA grants 510(k) clearance for Alere (NYSE:ALR-OLD)(ABT) unit Immunalysis' SEFRIA Fentanyl Urine Enzyme Immunoassay, the first regulatory approval for SEFRIA and the first 510(k)-cleared fentanyl ...
(Reuters) - Alere Inc said it initiated a voluntary recall of certain blood clot test strips in the United States following reports of nine serious adverse events that included bleeding related to the ...
Abbott Labs acquires large Alere patent portfolio in $5.8 billion deal, increasing diagnostic lineup
Abbott Laboratories (NYSE:ABT) of Chicago, IL, is poised to surge ahead in the global point-of-care medical diagnostics industry by acquiring Alere Inc. (NYSE:ALR) of Waltham, MA, in a $5.8 billion ...
The headquarters of Alere eScreen will move in October to this building at 8140 Ward Parkway in Kansas City. Kessinger/Hunter A technology company that provides employment screening applications for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback